Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,040.00
Bid: 6,030.00
Ask: 6,060.00
Change: 0.00 (0.00%)
Spread: 30.00 (0.498%)
Open: 5,950.00
High: 6,040.00
Low: 5,950.00
Prev. Close: 6,040.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison Investment Research Limited: 4imprint Group (FOUR) - Moving on up

1 Mar 2022 07:01

Edison Investment Research Limited Edison Investment Research Limited: 4imprint Group (FOUR) - Moving on up 01-March-2022 / 07:00 GMT/BST


 

London, UK, 1 March 2022

 

4imprint Group (FOUR) - Moving on up

4imprint's year-end trading update points to FY21 revenues of $787m, ahead of our expectation of $775m, up 41% on the prior year, after a strong Q4. PBT is indicated at the high end of the (wide) consensus range and we increase our estimate from $22.6m to $30.4m. Supply chain and inflation issues look set to continue, so margins will take longer to recover to the levels pre-COVID-19 pandemic, but the group has a degree of flexibility around substitution and pricing, which should mitigate the heaviest potential trading impact. 4imprint's long-term growth record, strong cash generation and robust balance sheet underpin the premium rating.

4imprint benefits from its scale, low fixed-cost base and limited capital requirements, attractive cash flow characteristics and cash positive balance sheet, all of which justify its premium rating. A DCF suggests a price of £33.29, while it trades on an FY22e EV/EBITDA of 21.5x, versus marketing services stocks on 10.5x. We expect continuing good growth will narrow this valuation gap.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Fiona Orford-Williams +44 (0)20 3077 5739 media@edisongroup.com

Max Hayes +44 (0)20 3077 5700 media@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter  www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1290081 01-March-2022 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
20th Sep 20174:06 pmRNSHolding(s) in Company
13th Sep 20173:24 pmRNSHolding(s) in Company
17th Aug 20178:59 amRNSHolding(s) in Company
3rd Aug 20179:06 amRNSDirector/PDMR Shareholding
1st Aug 20174:41 pmRNSSecond Price Monitoring Extn
1st Aug 20174:35 pmRNSPrice Monitoring Extension
1st Aug 20177:00 amRNSHalf-year Report
4th Jul 20172:58 pmRNSHolding(s) in Company
28th Jun 201710:18 amRNSHolding(s) in Company
22nd Jun 20173:11 pmRNSHolding(s) in Company
20th Jun 20179:29 amRNSNotice of Results
16th May 20179:30 amRNSHolding(s) in Company
11th May 20172:57 pmRNSEBT Purchase
11th May 20178:38 amRNSDirector/PDMR Shareholding
10th May 20174:30 pmRNSDirector/PDMR Shareholding
10th May 20172:25 pmRNSHolding(s) in Company
10th May 201712:06 pmRNSResult of AGM
9th May 20174:02 pmRNSHolding(s) in Company
9th May 20177:00 amRNSAGM Trading Statement
8th May 20179:38 amRNSHolding(s) in Company
4th Apr 20173:52 pmRNSAnnual Financial Report
30th Mar 20179:12 amRNSDirector/PDMR Shareholding
8th Mar 20177:00 amRNSFinal Results
19th Jan 20177:00 amRNSTrading Update and Notice of Final Results
9th Dec 20164:35 pmRNSPrice Monitoring Extension
8th Dec 20164:12 pmRNSEBT Purchase
28th Nov 201612:01 pmRNSEBT Purchase
22nd Nov 201611:03 amRNSEBT Purchase
9th Nov 201612:07 pmRNSSecond Price Monitoring Extn
9th Nov 201612:02 pmRNSPrice Monitoring Extension
2nd Nov 20167:00 amRNSTrading Update
7th Oct 20169:27 amRNSHolding(s) in Company
3rd Oct 20168:43 amRNSHolding(s) in Company
12th Aug 20168:53 amRNSHolding(s) in Company
11th Aug 20167:00 amRNSDirectorate Change
10th Aug 201611:10 amRNSHolding(s) in Company
2nd Aug 20167:00 amRNSHalf-year Report
16th Jun 20169:26 amRNSNotice of Results
19th May 20169:46 amRNSHolding(s) in Company
10th May 20164:39 pmRNSResult of AGM
10th May 201611:00 amRNSAGM Statement
9th May 201610:15 amRNSHolding(s) in Company
5th May 20168:33 amRNSHolding(s) in Company
3rd May 20168:38 amRNSTotal Voting Rights
25th Apr 20161:13 pmRNSHolding(s) in Company
19th Apr 201610:00 amRNSDirector/PDMR Shareholding
14th Apr 20167:00 amRNSDirector/PDMR Shareholding
8th Apr 201612:18 pmRNSBlock listing Interim Review
7th Apr 201611:27 amRNSAnnual Financial Report
29th Mar 20162:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.